J Thorac Oncol: The impact of low-dose CT (LDCT) screening for primary lung cancer on the risk of subsequent brain metastasis (BM).
BMS: ozanimod was approved by the FDA to treat UC and open S1P...
BMS finds new territory for its multiple sclerosis drug Zeposia
BMS two billion-dollar transactions in two days: introducing new drugs and expanding AI to help new drug R&D cooperation
Innovating the first-line treatment pattern for gastric cancer BMS, Merck, Baekje and other companies are developing in China
BM manual hydraulic forklift, 800-3000kg, 3 finger control
Abecma has just been approved for listing, BMS/Bluebird issued a paper explaining the mechanism of BCMA CAR-T resistance
The world's fifth CAR-T is approved, BMS and Gilead each have two equal shares, Novartis is surpassed
first, BMS achieved a "triple jump", Eli Lilly returned to TOP10, AZ fell out of the top ten
BMS Opdivo Adjuvant Treatment of Muscle Invasive Urothelial Carcinoma Approved in Europe
Compile Ke Ke
On March 29, Bristol-Myers Squibb (BMS) announced that the European Medicines
BMS' CAR-T cell therapy for multiple myeloma has been approved by the FDA
BMS combined Opdivo with Fotovda in the treatment of kidney cancer and AVEO...
BMS acquires new base results: 121 amines sold since 2020...
The Use of Soybean Agglutinin (SBA) for Bone Marrow (BM) Purging and Hematopoietic Progenitor Cell Enrichment in Clinical Bone Marrow Transplantation
BMS is working with insitro to develop drugs for ALS
The phase III drug study of Psoriasis in BMS met the standard
Can BMS get out of the "water inverse" phase of mergers and acquisitions in 2021?
Another multinational pharmaceutical executive is leaving! BMS has a wave of departures after the acquisition of the new base?
Sanofi poached Novaral and Gilead to target BMS MNC executives
BMS Opdivo and Yervoy first-line treatment of malignant thoracic mesothelioma are to be included in the priority review